Le Lézard
Classified in: Health
Subjects: POL, SCZ

AARP Responds to State of the Union Address


WASHINGTON, Feb. 4, 2020 /PRNewswire/ -- AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement in response to the State of the Union address this evening:

AARP national logo. (PRNewsfoto/AARP)

"AARP was encouraged to hear the President emphasize the need for Congress to take action on our nation's skyrocketing prescription drug prices.  

"It is outrageous that big drug companies have raised prices on over 500 prescription drugs already this year. The President has called for action. The House of Representatives has already acted. It is time for the Senate to pass bipartisan legislation to lower the price of prescription drugs and for Congress to send a final bill to President Trump for his signature.

"Americans should not have to continue paying the highest drug prices in the world, and AARP has been at the forefront of the fight to lower drug costs at the federal and state levels.

"Millions of Americans are looking to their elected leaders from both parties to put their differences aside and work together to lower drug prices. The time for federal action is now." 

About AARP
AARP is the nation's largest nonprofit, nonpartisan organization dedicated to empowering people 50 and older to choose how they live as they age. With a nationwide presence and nearly 38 million members, AARP strengthens communities and advocates for what matters most to families: health security, financial stability and personal fulfillment. AARP also produces the nation's largest circulation publications: AARP The Magazine and AARP Bulletin. To learn more, visit www.aarp.org or follow @AARP and @AARPadvocates on social media. 

 

SOURCE AARP


These press releases may also interest you

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...

at 02:54
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...

at 02:50
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...



News published on and distributed by: